Helicobacter pylori eradication therapy with Vonoprazan-amoxicillin-clarithromycin triple therapy - effect on Helicobacter pylori clarithromycin resistance
- Conditions
- Helicobacter pylori gastritis
- Registration Number
- JPRN-UMIN000019000
- Lead Sponsor
- ational Center for Global Health and Medicine.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 250
Not provided
1)not subject to upper endoscopy 2)eradication of H.pylori in the past 3)Subjects that have been administered antibiotics to be used as a systemic administration such as orally or by injection within 28 days 4)Subjects who are taking anticoagulants 5)Subjects that are oral anti-platelet agent 2 agent or more 6)Subjects having an upper gastrointestinal tract disease requiring treatment with proton pump inhibitors 7)Subjects with a merger or history of gastric acid hypersecretory disease (Zollinger-Ellison syndrome, etc.) 8) with a history of hypersensitivity to components of the drug to be used in the present study subjects 9) subject suspected of esophageal cancer or stomach cancer 10) subjects with a history of gastrectomy or vagotomy 11)pregnant or lactating subject
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method